Xtx Topco LTD Sana Biotechnology, Inc. Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$5.23 - $10.44 $95,442 - $190,519	18,249 New	18,249 $99,000
Q4 2023 Feb 13, 2024	BUY	$2.8 - $4.55 $84,789 - $137,783	30,282 New	30,282 $123,000
Q2 2023 Aug 14, 2023	SELL	$3.22 - $7.53 $10,101 - $23,621	-3,137 Reduced 23.73%	10,081 $60,000
Q1 2023 May 12, 2023	SELL	$3.11 - $4.92 $223,686 - $353,871	-71,925 Reduced 84.48%	13,218 $43,000
Q4 2022 Feb 14, 2023	BUY	$3.19 - $6.46 $271,606 - $550,023	85,143 New	85,143 $336,000
Q2 2022 Aug 15, 2022	SELL	$4.12 - $9.35 $42,872 - $97,296	-10,406 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.24 - $15.58 $54,527 - $162,125	10,406 New	10,406 $86,000

174

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $314M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.